You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
個股熱度排行 | 12月28日港股收盤
uSMART盈立智投 12-28 16:46

根據uSMART輿情監測數據,28日港股交易時段,市場關注指數最高的2只股票是藥明生物、中國電力。

12月28日—港股關注排行TOP2

輿情變化榜單

藥明生物

個股K線圖

關注度第一爲藥明生物,該股今日收盤上漲6.94%,報於57.80港元。近5個交易日累計上漲15.14%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

今日推介藥明生物、九毛九 並分析受壓股阜豐集團

藥明生物漲8.05% 附屬與啓德醫藥就核心偶聯技術授權及ADC新藥開發達成戰略合作

中國電力

個股K線圖

關注度第二爲中國電力,該股今日收盤上漲18.84%,報於3.28港元。近5個交易日累計上漲16.73%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

中國電力以12.65億元向中煤電力出售新源融合60%的股權

全球最大海上發電項目開建!中國電力攜綠電概念集體走強

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account